RT Journal Article
SR Electronic
T1 Essential Workers’ COVID-19 Vaccine Hesitancy, Misinformation and Informational Needs in the Republic of North Macedonia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.22.21268045
DO 10.1101/2021.12.22.21268045
A1 Fucaloro, S.
A1 Yacoubian, V.
A1 Piltch-Loeb, R.
A1 Harriman, N.
A1 Burmaz, T.
A1 Hadji-Janev, M.
A1 Savoia, E.
YR 2021
UL http://medrxiv.org/content/early/2021/12/26/2021.12.22.21268045.abstract
AB Introduction The COVID-19 pandemic is a global health crisis that as of December 2021 has resulted in the death of over 5.2 million people. Despite the unprecedented development and distribution of vaccines, hesitancy to take the vaccine remains a wide-spread public health challenge, especially in Eastern European countries. In this study we focus on a sample of essential workers living in the Republic of North Macedonia to: 1) Describe rates of vaccine acceptance, risk perception and sources of COVID-19 information, 2) Explore predictors of vaccine hesitancy, and 3) Describe informational needs of hesitant and non-hesitant workers.Methods Descriptive statistics were used to present frequencies of vaccine acceptance. Logistic regression was used to explore predictors of vaccine hesitancy based on sociodemographic characteristics, hesitancy to take other vaccines in the past, previous diagnosis of COVID-19, and individual risk perception of getting COVID-19. Chi square analysis was used to compare differences in informational needs between hesitant and non-hesitant individuals across socio-demographic groups.Results From a sample of 1003 individuals, 439 (44%) reported that they were very likely to get the vaccine, and the rest (66%) reported some level of hesitancy. Older age, Albanian ethnicity, post-secondary school education, previous diagnosis of COVID-19, previous vaccine acceptance of other vaccines, and increased risk perception of COVID-19 infection were all found to be negatively associated with vaccine hesitancy. In particular hesitant individuals, compared to the non-hesitant, wanted to have more information and reassurance that all main international agencies (i.e. FDA, WHO, EMA) were all in accordance in recommending the vaccine and that they would be free to choose if getting the vaccine or not without consequences (p<0.01).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received funding from the NATO Science for Peace and Security Programme [grant number SPS.MYPG5556] and the U.S. Department of Homeland Security (DHS), Science and Technology Directorate (Cooperative Agreement Number: 2015-ST-108-FRG005). The content of this manuscript as well as the views and discussions expressed are solely those of the authors and do not necessarily represent the official views of any of the above institutions, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol and survey instrument were approved by the Harvard T.H. Chan School of Public Health Institutional Review Board (protocol #IRB20-2032)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.